HIF Activator

Featured Inhibitors
Inhibitors (27)
Modulators (9)
Activator (1)
Antagonist (1)

Cat.No.	Product Name	Information	Product Use Citations	Product Validations
S5742	Deferoxamine mesylate	Deferoxamine mesylate is the mesylate salt of Deferoxamine, which forms iron complexes and is used as a chelating agent. Deferoxamine is a ferroptosis inhibitor that stabilizes HIF-1α expression and improves HIF-1α transactivity in hypoxic and hyperglycemic states in vitro. Deferoxamine decreases beta-amyloid (Aβ) deposition and induces autophagy.Please do not prepare stock solutions with normal saline or PBS, as precipitation may occur.	Cancer Cell, 2025, S1535-6108(25)00132-1 Nat Commun, 2025, 16(1):4919 Nat Commun, 2025, 16(1):6617

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S5742

Deferoxamine mesylate

Deferoxamine mesylate is the mesylate salt of Deferoxamine, which forms iron complexes and is used as a chelating agent. Deferoxamine is a ferroptosis inhibitor that stabilizes HIF-1α expression and improves HIF-1α transactivity in hypoxic and hyperglycemic states in vitro. Deferoxamine decreases beta-amyloid (Aβ) deposition and induces autophagy.Please do not prepare stock solutions with normal saline or PBS, as precipitation may occur.

Cancer Cell, 2025, S1535-6108(25)00132-1

Nat Commun, 2025, 16(1):4919

Nat Commun, 2025, 16(1):6617